Targeted Cognitive Behaviour Therapy to reduce key schizophrenia symptoms.

A trial funded by the Efficacy and Mechanism Evaluation (EME) programme, an MRC and NIHR partnership,  which looked at targeted treatment of cognitive behaviour therapy (CBT) to reduce levels of worrying and delusions of persecution (or paranoia) has been published in The Lancet Psychiatry.Delusions of being persecuted are unrealistic beliefs where someone believes...
Source: NIHR Evaluation, Trials and Studies News - Category: American Health Source Type: news